Watch Ticker

GRI Bio, Inc. Common Stock

Go to GRI Bio, Inc. Common Stock Website

$0.41

(%)
Live
Previous Close

$0.41

Day Range

$ - $

Previous Day Range

$ - $

Market Cap

$1.3 million USD

Day Vol.

Previous Day Vol.

Currency

USD

Primary Exchange

Nasdaq

GRI Bio Inc is a clinical-stage biotech company focused on discovering, developing, and commercializing therapies targeting serious diseases associated with dysregulated immune responses that to inflammatory, fibrotic, and autoimmune disorders. GRI B...

Community
  • 0 posts discussing
0

Watchers

0

Visitors

Recent News

LA JOLLA, CA, April 29, 2024 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or the “Company”), a biotechnology company advancing an innovative pipeline of Natural Killer T (NKT) cell modulators for the treatment of inflammatory, fibrotic and autoimmune diseases, today announced that its abstracts have been accepted for presentation at the 14th International Congress on Autoimmunity being held May 17-20, 2024 in Ljubljana, Slovenia.

Related tickers: GRI.

Read Full Article

Live webcast on Wednesday, May 1st at 3:00 PM ET

Related tickers: GRI.

Read Full Article
Trending Tickers
LASE

XNAS

$2.04
(%)
PACW

XNAS

$7.54
(%)
SMFL

XNAS

$3.58
(%)
SQ

XNYS

$69.47
(%)
MLGO

XNAS

$0.00
(%)